Literature DB >> 28427580

Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease.

Mouin S Abdallah1, Kaijun Wang2, Elizabeth A Magnuson3, Ruben L Osnabrugge4, A Pieter Kappetein4, Marie-Claude Morice5, Friedrich A Mohr6, Patrick W Serruys4, David J Cohen7.   

Abstract

BACKGROUND: In the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) trial, patients with 3-vessel or left main coronary artery disease (CAD) had improved long-term outcomes with coronary artery bypass graft (CABG) surgery compared with percutaneous coronary intervention (PCI) with drug-eluting stents (DES), improvements driven mainly by differences in myocardial infarction and repeat revascularization.
OBJECTIVES: This study compared the long-term quality-of-life benefits of DES-PCI versus CABG for patients with 3-vessel or left main CAD.
METHODS: Between 2005 and 2007, the SYNTAX trial randomized 1,800 patients with 3-vessel or left main CAD to either CABG or DES-PCI. Health status was assessed at baseline and at 1, 6, 12, 36, and 60 months by using the Seattle Angina Questionnaire (SAQ) and the 36-Item Short Form Health Survey.
RESULTS: At 5-year follow-up, CABG was superior to DES-PCI on several SAQ domains including angina frequency and physical function, as well as the role physical and role emotional scales of the 36-Item Short Form Health Survey. Subgroup analysis demonstrated a significant interaction between angiographic complexity (as assessed by the SYNTAX score) and angina relief (mean difference in the SAQ angina frequency score for CABG vs. PCI of -0.9, 3.3, and 3.9 points for low, intermediate, and high SYNTAX score patients, respectively; p = 0.048 for interaction).
CONCLUSIONS: Among patients with 3-vessel or left main CAD, both CABG and DES-PCI were associated with substantial and sustained quality-of-life benefits over 5 years of follow-up. In general, CABG resulted in greater angina relief, although the absolute treatment benefit was small. Angina relief at 5 years was enhanced with CABG among patients with high SYNTAX scores, a finding reinforcing the recommendation that CABG should be strongly preferred for such patients. (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery [SYNTAX]; NCT00114972).
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  coronary artery bypass graft; multivessel coronary artery disease; percutaneous coronary intervention

Mesh:

Year:  2017        PMID: 28427580     DOI: 10.1016/j.jacc.2017.02.031

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  13 in total

Review 1.  Cardiac surgery 2017 reviewed.

Authors:  Torsten Doenst; Hristo Kirov; Alexandros Moschovas; David Gonzalez-Lopez; Rauf Safarov; Mahmoud Diab; Steffen Bargenda; Gloria Faerber
Journal:  Clin Res Cardiol       Date:  2018-05-17       Impact factor: 5.460

Review 2.  Current Indications for Stenting: Symptoms or Survival CME.

Authors:  Suzanne V Arnold
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jan-Mar

3.  Coronary artery bypass grafting versus percutaneous coronary intervention in complex coronary artery disease: looking beyond clinical end-points.

Authors:  Aakash Garg; Hitesh Raheja; Marc Cohen
Journal:  Ann Transl Med       Date:  2017-12

Review 4.  Diabetes, heart failure, and myocardial revascularization: Is there a new message from the ISCHEMIA trial?

Authors:  Franz-Josef Neumann
Journal:  Herz       Date:  2022-08-12       Impact factor: 1.740

5.  Effect of coronary artery bypass grafting on quality of life: a meta-analysis of randomized trials.

Authors:  Ruth Masterson Creber; Arnaldo Dimagli; Cristiano Spadaccio; Annie Myers; Marco Moscarelli; Michelle Demetres; Matthew Little; Stephen Fremes; Mario Gaudino
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2022-05-05

Review 6.  Left Main Coronary Artery Disease in Diabetics: Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting?

Authors:  Logan Disney; Chandrashekhar Ramaiah; Meghna Ramaiah; Suresh Keshavamurthy
Journal:  Int J Angiol       Date:  2021-08-31

7.  The rest of the story: Long-term, patient-reported outcomes in cardiac surgery.

Authors:  William Z Chancellor; Irving L Kron
Journal:  J Thorac Cardiovasc Surg       Date:  2018-06-08       Impact factor: 5.209

Review 8.  Patient-Reported Outcomes in Cardiovascular Trials.

Authors:  Ruth Masterson Creber; Cristiano Spadaccio; Arnaldo Dimagli; Annie Myers; Brittany Taylor; Stephen Fremes
Journal:  Can J Cardiol       Date:  2021-05-08       Impact factor: 5.223

Review 9.  Revascularization for Left Main and Multivessel Coronary Artery Disease: Current Status and Future Prospects after the EXCEL and NOBLE Trials.

Authors:  Mohammed Al-Hijji; Abdallah El Sabbagh; David R Holmes
Journal:  Korean Circ J       Date:  2018-06       Impact factor: 3.243

10.  Real-World Outcomes of Revascularization Strategies in Patients With Left Ventricular Dysfunction and Three-Vessel Coronary Disease Stratified by Mitral Regurgitation.

Authors:  Qin Fan; Jun Liu; Yan Xu; Ruiqing Ni; Rui Xi; Fang Wang; Jian Hu; Hongyue Sun; Zhenkun Yang; Mi Zhou; Ruiyan Zhang; Qiang Zhao; Rong Tao
Journal:  Front Cardiovasc Med       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.